Last $0.0001 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/13/14 All times are local (Market data is delayed by at least 15 minutes).

imaging diagnostic systems (IMDS) Snapshot

Open
$0.0001
Previous Close
$0.0001
Day High
$0.0001
Day Low
$0.0001
52 Week High
02/10/14 - $0.0002
52 Week Low
08/20/13 - $0.0001
Market Cap
503.2K
Average Volume 10 Days
1.4M
EPS TTM
$-0.52
Shares Outstanding
5.0B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMAGING DIAGNOSTIC SYSTEMS (IMDS)

Related News

No related news articles were found.

imaging diagnostic systems (IMDS) Related Businessweek News

No Related Businessweek News Found

imaging diagnostic systems (IMDS) Details

Imaging Diagnostic Systems, Inc., a development stage medical technology company, develops and commercializes medical devices. The company offers computed tomography laser mammography (CTLM) system, which is a diffuse optical tomography CT-like scanner to detect breast abnormalities. Its CTLM system is an imaging modality that provides the potential of functional molecular imaging, which could visualize the process of angiogenesis and might be used by the radiologist to distinguish between benign and malignant tissue. The company also provides Laser Imager for Lab Animals (LILA), an optical helical micro-CT scanner that is designed to image various compounds, primarily green fluorescent protein derived from the DNA of jellyfish. Its LILA scanner is targeted at pharmaceutical developers and researchers who monitor cancer growth and who use multimodality small animal imaging in their clinical research. Imaging Diagnostic Systems, Inc. was founded in 1993 and is based in Fort Lauderdale, Florida.

imaging diagnostic systems (IMDS) Top Compensated Officers

Chief Operating Officer
Total Annual Compensation: $50.0K
Compensation as of Fiscal Year 2012.

imaging diagnostic systems (IMDS) Key Developments

Imaging Diagnostic Systems Inc. Announces Management Changes

On August 4, 2014, Imaging Diagnostic Systems Inc.'s board of directors, comprised of Richard J. Grable, II and Elizabeth J. Shotmeyer, appointed Investor's affiliates David Fong, Chunming Zhang and Qun Wang to the board of directors. Immediately thereafter, Mr. Grable and Ms. Shotmeyer resigned from the board. Deborah O'Brien also tendered her resignation from her position as senior vice president, effective August 1, 2014. David Fong is a certified public accountant and personal financial specialist and has been providing tax, accounting, and financial services in the United States since 1986, with focus on international tax and business. Chunming Zhang has been a Director and Vice President of the parent since December 2013. Qun Wang is an acupuncture physician in Orlando, Florida, practicing in Florida since 1994. He also served as vice president of the Acupuncture board of Florida from 2006 to 2009.

SEC Orders Hearings On Registration Suspension Or Revocation Against Imaging Diagnostic Systems For Failure To Make Required Periodic Filings

Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of Imaging Diagnostic Systems, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.

Imaging Diagnostic Systems Inc. Announces Management Changes

Imaging Diagnostic Systems Inc. announced that on March 17, 2014, the company's Board of Directors appointed Richard J. Grable II to serve as an Officer and Director. Immediately upon the appointment of Mr. Grable as an officer and director of the company, the company's Chief Executive Officer and Chairman, Linda B. Grable, and the company's Executive Vice President and Chief Financial Officer and Director, Allan L. Schwartz, resigned from their positions as officers and directors of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMDS:US $0.00 USD 0.00

IMDS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Greatbatch Inc $45.56 USD -0.02
Sandvik AB kr86.80 SEK -0.40
Symmetry Medical Inc $9.32 USD +0.02
Teleflex Inc $107.32 USD +0.37
View Industry Companies
 

Industry Analysis

IMDS

Industry Average

Valuation IMDS Industry Range
No financial data is available for IMDS.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMAGING DIAGNOSTIC SYSTEMS, please visit www.imds.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.